CA2229509C - Chemical signal-impermeable mask - Google Patents

Chemical signal-impermeable mask Download PDF

Info

Publication number
CA2229509C
CA2229509C CA002229509A CA2229509A CA2229509C CA 2229509 C CA2229509 C CA 2229509C CA 002229509 A CA002229509 A CA 002229509A CA 2229509 A CA2229509 A CA 2229509A CA 2229509 C CA2229509 C CA 2229509C
Authority
CA
Canada
Prior art keywords
mask
working electrode
chemical signal
mils
conductive material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002229509A
Other languages
French (fr)
Other versions
CA2229509A1 (en
Inventor
Ronald T. Kurnik
Janet Tamada
Michael Tierney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Animas Technologies LLC
Original Assignee
Cygnus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Inc filed Critical Cygnus Inc
Publication of CA2229509A1 publication Critical patent/CA2229509A1/en
Application granted granted Critical
Publication of CA2229509C publication Critical patent/CA2229509C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/002Electrode membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006Enzyme electrodes involving specific analytes or enzymes for glucose

Abstract

A chemical signal-impermeable mask (1) is positioned in the electrolyte flow such that the mask is between a source of chemical signal and a working electrode (4) which senses the chemical signal transported from the source (e.g., by diffusion). The configuration of the mask is such that the mask prevents substantially all chemical signal transport from the chemical signal source/having a radial vector component relative to a plane of the mask/and the catalytic face of the working electrode, thus allowing primarily only chemical signal transport that is substantially perpendicular to the place of the mask and the catalytic surface (6) of the working electrode. By reducing or eliminating chemical signal radial transport toward the working electrode, the mask thus significantly reduces or eliminates edge effects. By substantially reducing edge effects created by radial transport of chemical signal, it is possible to obtain a more accurate measurement of the amount (e.g., concentration) of chemical signal that is transported from a given area of source material.

Description

CHEMICAL SIGNAL-IMPERMZa~ABLE MASK
Field of the Invention s This invention relates generally to the detection of chemical signals that are diffused through a solid or semi-solid, or quiescent liquid surface, particularly where the chemical signals are associated with a medically important molecule.
se Backctroun3 of the Inverctian An electrode is the component in the electrochemical cell in contact with an electrolyte through which current can flow by electronic movement.
Electrodes, which are essential components of both 15 galvanic (current producing) and electrolytic (current using) cells, can be composed of a number of electrically conductive materials, e.g., lead, zinc, aluminum, copper, iron, nickel, mercury, graphite, gold, or platinum.
Examples of electrodes are found in electric cells, where 2o they are dipped in the electrolyte; in medical devices, where the electrode is used to detect electrical impulses emitted by the heart or the brain; and in semiconductor devices, where they perform one or more of the functions of emitting, collecting, or controlling the movements of 2s electrons and ions.
The electrolyte can be any substance that provides ionic conductivity, and through which electrochemically active species can be transported (e. g., by diffusion).
Electrolytes can be solid, liquid, or semi-solid (e. g., so in the form of a gel). Common electrolytes include sulfuric acid and sodium chloride, which ionize in solution. Electrolytes used in the medical field must ~ have a pH which is sufficiently close to that of the WO 97/10356 PC'1'/US96/11776 tissue in contact with the electrode (e.g., skin) so as not to cause harm to the tissue over time.
Electrochemically active species that are present in the electrolyte can undergo electrochemical reactions (oxidation or reduction) at the surface of the electrode.
The rate at which the electrochemical reactions take place is related to the reactivity of the species, the electrode material, the electrical potential applied to the electrode, and the efficiency at which the to electrochemically active species is transported to the electrode surface.
In unstirred electrolyte, such as quiescent liquid solutions and gel electrolytes, diffusion is the main process of transport of electrochemically active species is to the electrode surface. The exact nature of the diffusion process is determined by the geometry of the electrode (e. g., planar disk, cylindrical, or spherical), and the geometry of the electrolyte (e. g., semi-infinite large volume, thin disk of gel, etc.). For example, 2o diffusion of electrochemically active species to a spherical electrode in a semi-infinite volume of electrolyte differs from diffusion of electrochemically active species to a planar disk electrode. A constant and predictable pattern of diffusion (i.e., a diffusion 2s pattern that can be predicted by a simple equation) is critical in determining a correlation between the electrochemical current collected, and the concentration of the electrochemically active species in the electrolyte.
3o However, diffusion of electrochemically active species toward an electrode can not be predicted by a simple equation for every situation. For example, where the electrochemically active species diffuses through a disk-shaped electrolyte toward a smaller disk-shaped 35 electrode in contact with the electrolyte, the current observed at the electrode can not be predicted by a simple equation. In this latter situation, the inaccuracy in the diffusion model is caused by the combination of two different diffusion models. First, in the center of 0 5 the disk electrode the diffusion of the electroactive species towards the electrode is in a substantially perpendicular direction. Secondly, at the edges of the disk electrode the diffusion comes from both perpendicular and radial directions. The combination of 1o these two different diffusion patterns makes the total current collected at the disk electrode difficult to predict. In addition, the relative contributions of the diffusion fluxes from the axial and radial directions may change over time, causing further errors in predicted 1s current.
Summary of the Invention A mask which is substantially impermeable to the transport of a chemical signal is positioned in the chemical signal transport path moving toward a working 2o electrode which senses an electrochemical signal diffused through a material which is sonically conductive, which material comprises water and an electrolyte. More particularly, the mask of the invention is positioned on or in the sonically conductive material, such as an ion-25 containing gel, between an area from which the chemical signal is transported and the catalytic face of the working electrode used to sense the chemical signal. The configuration of the mask (e. g., shape, thickness, mask component(s)) is such that the mask prevents so substantially all chemical signal transport (from the chemical signal source) having a radial vector component ' relative to a plane of the mask and the catalytic face of the working electrode, thus allowing primarily only chemical signal transport (e.g., diffusion) that is substantially perpendicular to the place of the mask and the catalytic surface of the working electrode. The mask thus minimizes radial transport of the chemical signal to the working electrode and accumulation of chemical signal at the periphery of the working electrode. The mask thus ti significantly reduces or eliminates edge effects, since the chemical signal that reaches the electrode is primarily only that chemical signal that is transported in a direction substantially perpendicular to the 1o catalytic face of the working electrode. Substantially all transport of chemical signal to the working electrode surface via a path which includes an radial vector component (i.e., is not a path substantially perpendicular to the working electrode catalytic surface) 1s is prevented from occurring by the mask, since the mask blocks entry of potentially radially transported chemical signal at the source. By substantially reducing edge effects created by radial transport of chemical signal, it is possible to obtain a more accurate measurement of 2o the amount (e. g., concentration) of chemical signal that is transported from a given area of source material.
In one embodiment, the working electrode~is a closed polygon or closed circle. The mask has an outer perimeter which is equal to or greater than (i.e., 2s extends beyond) the outer perimeter of the working electrode. The mask has an opening, the opening being sufficiently small so that chemical signal that passes through the opening to the catalytic surface of the working electrode in a direction that is substantially 3o perpendicular to the plane of the mask, and thus, substantially perpendicular to the working electrode catalytic face.
In another embodiment, the working electrode is annular and the mask is composed of a solid, circular 3s piece concentrically positioned with respect to the working electrode such that the outer perimeter of the solid circular piece is circumscribed substantially within the inner perimeter of the annular working electrode. Thus chemical signal that passes with the s electrolyte flow and through the plane of the mask is substantially only that chemical signal that is transported from the chemical signal source in a direction that is substantially perpendicular to the working electrode catalytic face.
io In another embodiment, the mask is attached to a surface of a hydrogel patch, and the mask and hydrogel patch are provided as a single unit.
In another embodiment, the mask is an integral part of the housing for the sensor portion of a device i5 for monitoring the chemical signal.
In another embodiment, the mask is independent of any portion of the device with which it is to be used, i.e., the mask is not bound to another component but merely placed, by the user, in.contact with the 2o electrolyte containing material prior to use.
aspect of the invention is to provide a means that can be used with virtually any surface-contacting working electrode, and can enhance the performance of the electrode and the accuracy of measurements from the 2s working electrode.
Another aspect of the invention is to provide a means for accurately and consistently measuring the amount of a chemical signal present in a sample by minimizing the error created by chemical signal which 3o moves to the electrode with a radial vector component.
Another aspect of the invention is to provide a means for quickly, accurately, and continually measuring a chemical signal transported through an electrolyte containing ion conducting material, e.g., a hydrogel. By 3s using the mask of the invention with a working electrode as described herein, measurement of the chemical signal transported through the material in a path perpendicular to the electrode is achieved within a matter of seconds to minutes.
In accordance with an aspect of the present invention, there is provided an assembly for use in a monitoring device for monitoring a chemical signal, the chemical signal being a compound which diffuses through the skin of a subject, the assembly comprising:
a) an sonically conductive material having a first face having a chemical signal target area, the sonically conductive material comprising water and an electrolyte; and b) a mask characterized by being substantially impermeable to a chemical signal, the mask being positioned on a second face of the sonically conductive material opposite the first material face such that chemical signal transported through a plane of the mask, through the sonically conductive material, and toward the chemical signal target area is substantially only that chemical signal transported in a direction substantially perpendicular to the chemical signal target area.
In accordance with another aspect of the present invention , the mask has an opening through which chemical signal flows in a direction substantially perpendicular to the target area.
In accordance with another aspect of the present invention, the opening in the mask constitutes an area which is in a range of 1~ to 90~ of an area encompassed by the entire mask plus opening.
In accordance with another aspect of the present invention, the opening in the mask has a perimeter equal to or circumscribed within an outer 6a perimeter of the target area.
In accordance with another aspect of the present invention, the mask is solid and the target area is annular.
In accordance with another aspect of the present invention, the sonically conductive material comprises:
i) a hydrophilic compound which forms a gel in water, which compound is present in an amount of about 4~ or more by weight based on the weight of the sonically conductive material;
ii) a hydrogel comprising about 955 or less water; and iii) a chloride containing salt.
In accordance with another aspect of the present invention, the sonically conductive material comprises glucose oxidase and the chemical signal is glucose.
In accordance with another aspect of the present invention, the first and second faces of the sonically conductive material are coplanar and each has a surface area in a range of from about 0.5 to about 10 cm2 and the material has a thickness in a range of from about mils to about 50 mils.
In accordance with another aspect of the present invention, the mask has a thickness in a range of about 0.5 mil to 10 mils and the sonically conductive material has a thickness in a range of about 10 mils to 50 mils.
In accordance with another aspect of the present invention, the mask has a thickness in a range of about 0.5 mil to 10 mils and the sonically conductive 6b material has a thickness in a range of about 10 mils to 60 mils.
In accordance with another aspect of the present invention, the mask has a thickness in a range of about 0.01 mil to 5 mils and the sonically conductive material has a thickness in a range of about 5 mils to 60 mils.
In accordance with another aspect of the present invention, the mask has a thickness in a range of about 0.01 mil to 10 mils and the sonically conductive material has a thickness in a range of about 10 mils to 60 mils.
In accordance with another aspect of the present invention, the mask has a thickness in a range of about 0.5 mil to 5 mils and the sonically conductive material has a thickness in a range of about 5 mils to 60 mils.
In accordance with another aspect of the present invention, there is provided a sensor assembly for use with a chemical signal monitoring device, comprising;
a sensor housing having a top portion and a bottom portion, the bottom portion defining a bottom portion opening a chemical signal impermeable mask positioned between the top portion and the bottom portion, the mask having a surface area greater than or equal to the surface area of the bottom portion opening, and defining a mask opening, the mask being positioned so that the mask opening and the bottom portion opening are aligned;
and 6~
a working electrode positioned in the top portion of the sensor housing;
wherein prior to use of the device a hydrogel is inserted between the sensor housing bottom portion and top portion such that when the sensor assembly is closed, the top portion is positioned directly over the bottom portion such that a first hydrogel face contacts the mask, and the working electrode is in contact with a second hydrogel face opposite the first hydrogel face, the working electrode being positioned directly opposite the bottom portion opening, wherein chemical signal transported through a plane of the mask, through the hydrogel and toward the working electrode is substantially only that chemical signal transported in a direction substantially perpendicular to the working electrode.
In accordance with another aspect of the present invention, the hydrogel comprises glucose oxidase, the mask is impermeable to glucose, and the working electrode comprises platinum.
In accordance with another aspect of the present invention, the surface area of each the first and second hydrogel faces is in a range of about 0.5 cm2 to 10 cm2 .
In accordance with another aspect of the present invention, the mask has a thickness in a range of about 0.5 mils to 10 mils.
In accordance with another aspect of the present invention, the mask has a thickness in the range of about 0.01 mils to 10 mils.
In accordance with another aspect of the present invention, the hydrogel has a thickness in a 6a range of about 10 mils to 50 mils.
In accordance with another aspect of the present invention, the hydrogel has a thickness in a range of about 5 mils to 60 mils.
In accordance with another aspect of the present invention, the assembly has a total thickness in a range of about 5 mils to 50 mils.
In accordance with another aspect of the present invention, the assembly has a total thickness in the range of about 5 mils to 70 mils.
In accordance with another aspect of the present invention, there is provided an assembly for use in monitoring a chemical signal, comprising:
a) an sonically conductive material comprised of water, electrolyte and an enzyme;
b) a working electrode having a catalytic surface comprised of a material selected from the group consisting of platinum, palladium, nickel, and oxides, dioxides and alloys thereof, the catalytic surface contacting a first face of the sonically conductive material; and c) a chemical signal impermeable mask positioned on a second face of the sonically conductive material (a) opposite the first sonically conductive material face and opposite the catalytic surface of the electrode (b), the mask having an outer perimeter which is equal to or extends beyond an outer perimeter of the working electrode (b) and having an opening therein which has a perimeter which is equal to or circumscribed within the outer perimeter of the working electrode, wherein chemical signal transported through a plane of the mask, through the sonically conductive material, and toward the 6e catalytic surface of the electrode is substantially only that chemical signal transported in a direction substantially perpendicular to the catalytic surface of the electrode.
In accordance with another apsect of the present invention, in the assembly for use in monitoring a chemical signal, the material (a), electrode (b), and mask (c) are such that the mask blocks substantially all chemical signal flowing to the catalytic surface which is not flowing in a direction substantially perpendicular to the catalytic surface and allows substantially all chemical signal to flow to the catalytic surface which is flowing to that surface in a substantially perpendicular path.
In accordance with another apsect of the present invention, in the assembly for use in monitoring a chemical signal, the first and second faces of the sonically conductive material each have a geometric surface area in a range of about 0.5 cm2 to 10 cm2 and the material has a thickness in range of about 5 to about 50 mils, further wherein the working electrode (b) has a geometric surface area in a range of about 0.25 to about 5.0 cm2, and still further wherein the mask (c) has a thickness in a range of about 0.5 mil to about 10 mils.
In accordance with another apsect of the present invention, in the assembly for use in monitoring a chemical signal, the first and second faces of the sonically conductive material each have a geometric surface area in a range of about 0.5 cmz to 10 cm2 and the material has a thickness in range of about 5 to about 60 mils, further wherein the working electrode (b) has a geometric surface area in a range of about 0.05 cm2 to 6f about 8 cm2, and still further wherein the mask (c) has a thickness in a range of about 0.01 mil to about 10 mils.
In accordance with another aspect of the present invention, there is provided an assembly for use in a monitoring device for monitoring a chemical signal, comprising:
a) an sonically conductive material;
b) a mask characterized by being impermeable to the chemical signal, the mask being positioned between sonically conductive material and a source of chemical signal; and c) a working electrode which measures chemical signal transported from the source of chemical signal wherein the mask is concentric to the working electrode and further wherein the chemical signal that passes through a plane of the mask is that chemical signal that is transported from the source to the catalytic surface in a manner which is substantially perpendicular to the catalytic surface.
In accordance with another aspect of the present invention, in the assembly for use in a monitoring device for monitoring a chemical signal, the sonically conductive material is a hydrogel having an enzyme therein and the catalytic surface is comprised of a material selected from the group consisting of platinum, palladium, nickel, oxides thereof, dioxides thereof and alloys thereof.
In accordance with another aspect of the present invention, there is provided a method of measuring a concentration of a chemical present in a bloodstream of a mammalian subject, comprising the steps of:

6g contacting a mammalian subject's skin with a sensor assembly comprising;
a) an sonically conductive material in contact with the skin;
b) a working electrode in contact with the sonically conductive material the working electrode having a catalytic surface; and c) a mask having an opening therein wherein the mask is positioned between the skin and the working electrode;
transporting a chemical through the skin and sonically conductive material whereby the mask blocks flow to the catalytic surface except for flow substantially axial to the catalytic surface;
monitoring an electrical signal generated at the working electrode by catalytic conversion into an electric signal at the catalytic surface of the working electrode;
wherein the electrical signal generated at the working electrode over a given period of time is correlated with a concentration of chemical present in the bloodstream of the mammalian subject.
In accordance with another aspect of the present invention, in the method of measuring a concentration of a chemical present in a bloodstream of a mammalian subject, the assembly further comprises:
d) an electroosmotic electrode in contact with the sonically conductive material and said transporting is accomplished by applying an electrical current to the electroosmotic electrode.

6h In accordance with another aspect of the present invention, in the method of measuring a concentration of a chemical present in a bloodstream of a mammalian subject, the chemical is glucose, the sonically conductive material is a hydrogel, and the catalytic surface of the working electrode comprises a material selected from the group consisting of platinum oxide and platinum dioxide.
In accordance with another aspect of the present invention, in the method of measuring a concentration of a chemical present in a bloodstream of a mammalian subject,the chemical is glucose, the hydrogel comprises a hydrophilic polymer, water and glucose oxidase.
In accordance with another aspect of the present invention, there is provided a method of measuring a glucose concentration in a mammalian subject, the method comprising:
contacting a first surface of an sonically conductive material with a skin surface wherein the sonically conductive material comprises water and glucose oxidase;
contacting a second surface of the conductive material with a working electrode;
applying current to the skin in an amount sufficient to draw glucose into the conductive material whereby the glucose is converted to gluconic acid and hydrogen peroxide and the hydrogen peroxide is drawn to the working electrode; and positioning a mask impermeable to the hydrogen peroxide between the skin surface and a surface of the working electrode so as to shield the working electrode surface from hydrogen peroxide moving to the working 6i electrode surface via any path other than a path substantially axial to the working electrode surface.
In accordance with another aspect of the present invention, the mammalian subject is a human.
An aspect of the invention is to provide a disposable assembly which makes it possible to proportionally measure a chemical signal by conversion into an electrical signal, where the electrical signal can be measured and accurately correlated with the amount of chemical signal present in a given source (e.g., the amount of chemical signal present in and/or below a section of skin, or in a hydrogel patch in contact with the working electrode).
An advantage of the invention is that use of the mask with a working electrode and hydrogel allows for measurement of very small amounts of an electrochemical signal. For example, the mask of the invention can be used in conjunction with a working electrode, electroosmotic electrode and hydrogel system for monitoring glucose levels in a subject. An electroosmotic electrode (e. g., reverse iontophoresis electrode) can be used to electrically draw glucose into the hydrogel. Glucose oxidase (GOD) contained in the hydrogel catalyzes the conversion of glucose to generate a reaction product (hydrogen peroxide) which can be proportionally converted to an electrical signal. The electroosmotic electrode is switched off and the working electrode of the invention is turned on. The working electrode catalyzes the resulting chemical signal into an electrical signal which is correlated to the amount of chemical signal. This system allows for the continuous and accurate measurement of an inflow of a very small amount of glucose (e. g., glucose concentrations 10, 500, or 1,000 or more times less than the concentration of glucose in blood).

Another advantage is that the mask is easily and economically produced and is disposable.
A feature of the mask and the device used therewith is that it is flat (e. g., a disk with s substantially planar surfaces), thin (e. g., 0.5 to. l0 mils), impermeable to chemical signal flow with the electrode/mask/hydrogel assembly having a surface area on each face in the range of about 0.5 cm2 to l0 cm2.
A feature of the mask is that where the mask 1o includes an opening, the opening has substantially the same dimensions or smaller as the working electrode i.e., the outer perimeter of the opening is circumscribed within the outer perimeter of the catalytic surface of the working electrode.
1s These and other aspects, advantages and features of the present invention will become apparent to those persons skilled in the art upon reading the details of the composition, components and size of the invention as set forth below reference being made to the accompanying 2o drawings forming a part hereof wherein like numbers refer to like components throughout.
Hrje Descriot;on of the Drawin_Q
Figure 1 is an overhead schematic view of a disc or donut shaped embodiment of the mask of the invention.
25 Figures 2A and 28 are cross-sectional views of embodiments of an electroosmotic electrode/working electrode/hydrogel patch assembly with a mask according to the invention.
Figure 3 is a cross-sectional view of an 3o electroosmotic electrode/sensing electrode/hydrogel patch assembly without a mask according to the invention.
Figure 4 is a schematic representation of the reaction which glucose oxidase (GOD) catalyzes to produce gluconic acid and hydrogen peroxide; hydrogen peroxide is then catalyzed at the working electrode into molecular oxygen, 2 hydrogen ions, and 2 electrons, the latter of which generates an electrical current. ., Figure 5 is a cross-sectional schematic~view of a mask of the invention provided below a hydrogel patch.
Figure 6 is an overhead schematic view of a sensor housing containing electroosmotic and working electrodes and a mask. .
Figure 7 is a graph~showing the measured 1o electrical current at the working electrode in the absence of the mask for different intervals as a function of time:
Figure 8 is a graph showing the measured electrical current at the~working electrode in the presence of the mask for different intervals as a function of time.
Figure 9 is a graph showing a comparison of the measured electrical-current at the working electrode either with the mask or without the mask as a function of 2o interval number.
Besc~iption of the Preferred Embodiments Before the mask of the present invention and assembly comprising such is described and disclosed it is to be understood that this invention is not limited to the particular components or composition described as such may, of course, vary. It is also to be understood that the terminology used herein~is for the purpose of describing particular embodiments only, and is not intended to be limiting since the scope of the present 3o invention will be limited only by the appended claims.
It must be noted that as used in this specification and the appended claims, the singular forms ''a", "an" and "the" include plural referents unless the context clearly dictates otherwise. .Thus, for example, _ g _ reference to "a molecule" includes a plurality of molecules and different types of molecules.
Unless defined otherwise all technical and scientific terms used herein have the same meaning as s commonly understood by one of ordinary skill in the art to which this invention belongs. Although any materials or methods similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials io are now described. All publications mentioned herein are incorporated herein by reference for the purpose of describing and disclosing the particular information for which the publication was cited in connection with.
pef initions 1s The term "mask," '~impermeable mask," or "mask of the invention" means a thin (less than 50 mils, preferably 0.5 mil to 5 mils in thickness), substantially flat piece of material that, when,positioned within the transport path of chemical,signal moving toward a working 2o electrode, reduces or prevents transport of chemical signal in a radial direction from the chemical signal source. The mask can be positioned on a face of the sonically conductive material, or can~be positioned at any position within the sonically conductive material 2s (e.g., such that the mask is contacted by material on each of its planar surfaces). In one exemplary configuration, the mask has an opening, which opening is substantially. the same shape and size (e. g., smaller than or equal to) that of the working electrode. Thus, the 30 outer perimeter of the opening is circumscribed substantially within~the outer perimeter of the 'catalytic ' surface of the working electrode. When the opening is circular, the diameter is equal to or less than the ' diameter of the circular catalytic surface of a working electrode with which.the mask is to used. In an alternative exemplary configuration, the mask is a solid piece of material (i.e., does not-have an opening), and is used in conjunction with, for example, an annular working electrode. This type of mask is concentrically .
positioned with respect to the working electrode, s'o that chemical signal does not'enter the region substantially concentric to the annular working electrode. The mask is composed of a material that is substantially impermeable to to the flow of chemical signal that, is to be detected.
The mask and/or the mask opening are of a size sufficient to allow a detectable amount of chemical signal to reach the working electrode, while reducing or preventing entry of chemical signal into the electrolyte flow path that has a potential to be transported (eg., by diffusion) in a radial direction toward an edge of~the working electrode. Thus, the mask substantially eliminates "edge effect" flow, i.e., the chemical signal impermeable mask area prevents chemical signal from contacting the 2o electrode unless the signal flows substantially perpendicular to the surface of the working electrode.
The term "working electrode" means an electrode that detects a chemical signal by catalyzing the conversion of a chemical. compound into an electrical signal (e.g., conversion of hydrogen peroxide into 2 electrons, molecular oxygen, and 2 hydrogen ions).
The term "catalytic surface'.' or "catalytic face"
means the surface of the working electrode that: 1) is in contact with the surface of an ionically conductive 3o material which comprises an electrolyte and allows for the flow of chemical signal; 2) is composed of a catalytic material (e. g., carbon, platinum,~palladium, nobel metal, or nickel and/or oxides and dioxides of any of these); and 3) catalyzes the.conversion of the chemical signal into an electrical signal (i.e., an electrical current) that is monitored and correlated with an amount of chemical signal present at the electrode.
."Chemical signal," ''electrochemical signal," or "electrochemically active compound" means the chemical compound that is ultimately converted to an electrical signal and measured by the working electrode in conjunction with a monitoring device. Chemical signal which moves toward the working electrode at an angle, i.e., includes a radial vector component, is blocked by to the mask. "Chemical_signals" can be:, 1) directly converted into an electrical signal by chemical reaction at the catalytic face of the electrode; or 2) indirectly converted into an electrical signal'by the action of one or more catalysts. For example, the chemical signal glucose is indirectly. converted into an electrical signal by reactions driven by two catalysts. A first catalyst, the enzyme glucose oxidase (GOD), converts glucose into gluconic acid and hydrogen peroxide. Hydrogen peroxide is then converted to an electrical signal by a second 2o catalyst which second catalyst is the catalytic material (e.g., metal.or metal oxide on the catalytic face of the working electrode.
"Ionically conductive material" means a material that provides ionic conductivity, and through which electrochemically active species can~be transported (e.g.,.by diffusion). The ionically conductive material can be, for example, a solid, liquid, or semi-solid (e.g., in the form cf a gel) material that contains an electrolyte, which can be composed primarily of water and 3o ions (e. g., sodium chloride). Generally, the material comprises water at 50% or more by weight of the total material weight. The material can be in the form of a gel, a sponge or pad (e. g., soaked with an electrolytic solution), or any other material~that can contain an ' 3s electrolyte and allow passage of electrochemically active species, especially the chemical signal of interest, through it. An exemplary sonically conductive material in the form of a hydrogel is described in PcT wo 97/o2s11, published January 30, 1997.
A "chemical signal target area" is an area on a surface of an sonically conductive material toward which chemical signal transport is desired. The chemical signal target area is~generally an area of the sonically to conductive material. that, during chemical signal monitoring, is in contact with a chemical signal sensing means (e. g., a catalytic face of a'working electrode), and is of the same size and shape as the portion of the chemical signal sensing means in contact with the is sonically conductive material surface (e. g., the same size and shape as the catalytic face of the working electrodej. For example, where the chemical sensing means to be used with the sonically conductive material is a circular working electrode, the chemical signal.
2o target area is a circular area of the sonically conductive material face that contacts the catalytic surface of the circular working electrode during chemical signal monitoring. In another example, where the chemical sensing means to be used with the sonically 2s conductive material is an annular working electrode, the chemical signal target area is an annular area of the sonically conductive material face that contacts the catalytic surface of the circular working electrode during chemical signal monitoring.
3o Mask lGeneraW
The invention must provide some basic characteristics in order to be useful for its intended purpose, which is to inhibit contact between a working electrode and radially inward transported chemical signal, particularly the form of the chemical signal that can be catalyzed into an electrical signal at the catalytic surface of the electrode (e. g., hydrogen peroxide that results from conversion of the chemical signal glucose).
For example, the mask of the invention can be used in connection with any metabolite monitoring device, where the device contains a working electrode that detects a chemical signal that is transported from one area (e. g., the skin and tissues: below the skin) through an ion conducting material (e.g., a hydrogel) to the electrode surface. Examples of such devices include those described in PCT application serial no.
PCT/GB93/00982.
Further exemplary devices, hydrogels, and additional components for use with the present invention are deSCribed in PCT WO 97/02811, published January 30, 1997 and in PCT WO 97/10499, published March 20, 1997.
which applications disclose inventions which were invented under an obligation to assign rights to the same entity to which the rights in the present invention were invented under an obligation to assign a An exemplary sonically conductive material suitable for use with the invention is a hydrogel composed of a hydrophilic compound, water, and a salt.
The hydrophilic compound forms a gel in the presence of water, and is generally present in the gel in an amount of about 4% or more by weight based. on the total gel weight. The gel contains water in an amount of about 95%
or less based on the weight of the hydrogel. The salt can be any salt that ionizes readily in water and facilitates electric conductivity through the gel, WO 97/10356 PCTlUS96/11776 preferably a chloride containing salt (e. g., NaCl, KC1, etc. ) .
Regardless of the composition of the sonically conductive material, one face of the material has a s chemical signal target area. The target area is the area .
on a face of the material toward which chemical signal transport is desired, e.g., the area of the material face that will be in contact with the catalytic face of'a working electrode during chemical signal sensing.
to Preferably, the target area of the.ionically conductive material is used with a working electrode that has a catalytic face.having approximately the same shape and size as the target area (e. g., circular, annular,. etc.).
During monitoring, the mask is positioned on a second 15 sonically, conductive , material face opposite the first material face having the target area, such that chemical signal that diffuses from the chemical signal source, through a plane of the mask, through the sonically conductive material, and toward the chemical signal 2o target area is substantially only that chemical signal that is transported in a direction substantially perpendicular to the chemical signal target area.
An exemplary monitoring device that can be used in connection with the mask of the invention is generally 25 composed of: 1) a hydrogel patch, one face of which is contacted with a source of biologically important molecules such as the skin of a mammalian subject; 2) an electroosmotic electrode which is positioned on the face of the hydrogel patch opposite the face in contact with 3o the mammalian subject s skin; 3) a working electrode having a catalytic material on at least. its catalytic face, the catalytic face of the electrode being that face in contact with the same face of the hydrogel as the electroosmotic electrode; 4) a means for generating an 35 electrical current, through the electroosmotic electrode, the electrical current serving to electrically draw molecules through the mammalian subject's skin, into the hydrogel patch, and toward_the catalytic face of the working electrode; and 5) a monitoring means for monitoring, electrical current generated at the catalytic face..of 'the working electrode. Alternatively, the chemical signal can enter the hydrogel by passive diffusion, i.e., the assembly can be used without an electroosmotic electrode.
1o Such a monitoring device can be used to monitor levels of a metabolically important compound in, for example, the bloodstream of a mammalian subject (e.g., a human subject). As used herein, the metabolic compound in this example is termed the "chemical signal." For example, the metabolic~compound (and chemical signal) can be glucose. That chemical signal is converted to.a useful chemical signal and then converted to.an electrical signal as shown in Figure 4. The electroosmotic electrodes are used to electrically draw 2o glucose~molecules through the mammalian subject's skin, into the hydrogel, and toward the catalytic face of the working electrode. The hydrogel contains the enzyme glucose oxidase (GOD), which converts the glucose into gluconic acid and hydrogen peroxide. The hydrogen 2s peroxide is then converted into molecular oxygen, 2 hydrogen ions, and 2 electrons, the latter of which generates an electrical current in the working electrode (see.Figure 4)~. The electrical current is measured by the attached monitoring device,_and correlated with the 3o amount of glucose present in the subject's bloodstream.
An assembly of the invention comprised of an electrode~and mask positioned on either side of a.
hydrogel is used with a monitoring device as described above by positioning the mask between mammalian subject's 35 skin and the face of the hydrogel in contact with the subject's skin, such that chemical signal that diffuses from the subject's skin and past the plane of~the mask is only that chemical signal that is transported in a path substantially perpendicular to the catalytic face of the working electrode. It is important that the mask does not completely occlude contact of the ionically conductive material (e.g., the hydrogel) with the chemical signal source (e. g., the subject's skirt).
An exemplary assembly of the invention is shown in 1o Fig. 2A, where the working electrode 4 and mask 1 are circular, and .the mask has an opening 2 that is positioned so that it is directly beneath the working electrode 4 on the opposite face of the gel 3. Because the mask is impermeable to the chemical signal (e. g., 1s glucose), chemical signal is electrically drawn via a substantially perpendicular path only through the opening in the mask. An additional exemplary assembly of the invention is shown in Fig. 2B, where the working electrode is annular (circular with a circular opening in 2o the center), and the mask 1 is a solid, circular piece positioned concentric to the working electrode such that the outer perimeter of the mask 1 is substantially circumscribed within the inner perimeter of the annular working electrode 4. In this embodiment, the annular 2s working electrode extends from approximately the.outer perimeter of the mask~to the outer perimeter of the ionically~conductive material (e.g., hydrogel) used in conjunction with the mask 1 and working electrode 4. For example, where the radius of the a circular hydrogel is 30 0.95 cm, the radius of the mask can be about 0.5 cm and the width of the working~electrode is about o.45 cm.
The position of the mask, and the inhibition of the entry of glucose into gel areas other than that directly beneath the working electrode minimizes the 35 radial component of chemical~signal transport. Reduction of radial transport of the chemical signal toward the working electrode reduces accumulation of such radially transported compound at the periphery.of the electrode, thereby reducing the edge effects~associated with. this s phenomenon. . It is recognized that the mask can allow for a small amount of radial chemical signal transport from the chemical signal source toward the working electrode where, for example, the error in measured electrical current associated with electrochemical conversion of the to radially transported chemical signal is of a magnitude that does not significantly affect the accuracy of the measurement of the amount of chemical signal (e.g., the concentration of chemical signal in a subjects bloodstream). Thus, for example, where the mask has an is opening, the opening can be slightly larger than the diameter of the working electrode used in conjunction with the mask.
The (ij size or geometric surface area of the working electrode, (2) thickness of the gel, (3) size of 2o the opening in the mask, and (4) width of the mask surrounding the opening are all interrelated to each other. For example, when the thickness of the gel is~
increased the size of the opening must be decreased to obtain the same degree of. elimination of radially 2s transported chemical signal.. The smaller the opening in the mask the greater the ability to block radial transport of chemical signal. Although it is desirable to decrease radial transport of the chemical signal, it is also desirable to maximize the chemical signs-1 3o received and the chemical signal is decreased by a smaller opening in the mask.
For reasons that may relate to factors such as the build up of undesired materials, components such as the hydrogel, mask and the electrodes must be easi~.y 3s replaceable by a patient in a convenient manner.

Accordingly, an assembly of these components must have some structural integrity, and provide for the detection of the chemical signal of interest. In that the device is preferably small (e.g., hand held, e.g., the size of a s watch to be worn on the wrist of a patient), it is necessary that the assembly of components be particularly thin. The mask generally has a thickness of about 0.5 to mils (1 mil equals one thousandth of an inch) and the hydrogel has a thickness in the range of about 5 mils to 10 60 mils, generally about 10 mils to 60 mils, normally about~600 microns (about 24 mils).
In order to accurately measure the amount of a chemical. signal (e. g., the amount of hydrogen peroxide generated by GOD catalysis of glucose) and be 1s sufficiently large to be manipulated, the device cannot be too thin and cannot be too small. The overall surface area of the hydroge~l on a single surface should_be in the range of about 0.25 cm2 to about 10 cm2, preferably about 0.50 cm2 to 5 cm2. The electrodes of the entire 2o monitoring device, which include both electroosmotic and working.electrodes, must have a total.surface area that is less than that of the hydrogel patch. In general, the surface area of a mask (the area of the mask, and the opening where applicable) suitable for use in the 25 monitoring device ranges from about 0.1 cm2 to about 6 cm2, preferably about 0.25 cm2 to 2.0 cm2, more preferably about 1.0 cm2.
l~sic Structure Figure 1 is an overhead schematic view of an 3o exemplary mask of the invention. The mask may be any configuration but is.preferably donut shaped as per Figure 1, with an outer perimeter that is equal to or larger than that of the working electrode and/or is substantially the same as the hydrogel patch used in conjunction with the mask. The mask opening is generally equal in. size to about 50% of the area of the working electrode,~ 20%. In general, the mask opening constitutes an area that is in the range of 1% to 90% of the area encompassed by.the mask plus the opening. The mask 1 is disc-shaped, and has a diameter equal to or less than the diameter of the hydrogel patch used in conjunction with the mask, the diameter being in the general range of about 0.5 cm to 3.0 cm, generally about l0 1.9 cm. In general, the range of the surface area of the hydrogel patch used in conjunction with the mask is from about 0.5 cm2 to about 10 cm', preferably in the range of about 1 cm2 to about 5 cm2. The mask 1 defines.an opening 2 positioned~substantially in the center of the mask 1.
The diameter of opening 2 is less than or equal to the diameter of the catalytic surface. of the working electrode that is to be used in conjunction with the mask, generally in the range of about 0.4 cm. Normally, the mask opening constitutes-an area that is about 5/8 ~ 15% of the total area encompassed by the catalytic face of the working electrode, equal to, or slightly larger than the catalytic face of the working electrode (e. g., 100.5% to 105% of the catalytic surface area).
Alternatively, the mask can be a composed of a 2s solid, circular piece for use with, for example, an annular working electrode. The solid, circular mask is concentrically positioned with respect to an annular working electrode such that the outer perimeter of the solid circular piece is circumscribed substantially 3o within the inner perimeter of the annular working electrode. Thus'chemical signal that diffuses from the chemical signal source and through the masks) is substantially only that chemical signal that diffuses from the chemical signal source in a direction that is 3s substantially perpendicular to the plane of the mask, and thus, substantially perpendicular to the annular working electrode catalytic face.
The mask is preferably thin, generally having a thickness in the range of aboutØ01 mil to 10 mils, normally about 0.5 mil to 5 mils (1 mil equals one-thousandth of an inch).. The working electrode used in conjunction with the mask of the invention generally has a geometric surface about 5% to 90%, preferably about 10%
to 80% of the geometric surface of the~hydrogel.
1o The mask is composed of a material that is substantially impermeable to the.chemical signal to be detected (e.g., glucose), and can be permeable to substances other than the chemical signal of interest.
By "substantially impermeable" is meant that.the~mask 1s material reduces or eliminates chemical signal transport (e. g., by diffusion). The mask can allow for a low level of chemical signal transport, with the proviso that chemical signal that passes through the material of the mask does not cause significant edge effects at the 2o working electrode use in conjunction with the mask.
Examples of materials that can be used to form the impermeable mask include mylar, polyethylene, nylon and various other synthetic polymeric material. The mask can be composed of a.single material, or can be composed of 2s two or more materials (e.g., the mask is composed of multiple layers of the same or different materials) to form a-chemical signal-impermeable composition.
In general, the size of the mask (i.e., diameter, surface area, thickness, etc.), the geometry of the mask 30 (e.g., circular, oval, annular, polygonal, etc.), the size (e. g., diameter; surface area, etc.) and/or geometry (e. g., annular, circular, oval, polygonal) of a mask opening through which the chemical~signal is to be detected, compositions of the mask (e. g., type and number 35 of materials, number of layers, chemical signal to which the mask is permeable), the number of mask used in an assembly of the invention (i.e., the number and position of the masks in the electrolyte flow path between the catalytic surface of the working electrode and the s chemical signal source) and other characteristics of .the mask will vary according to a variety of factors such as, for example, the diameter of the hydrogel patch, the diameter of the working electrode, the diameter of the electroosmotic/working electrode assembly, the chemical to signal to be detected, the characteristics of the chemical signal's path of transport (e. g., the diffusion characteristics of the chemical signal), and the geometry and size of the monitoring device.
Methods for making the mask include die cutting 15 and stamping. according to methods well known in the art.
Most preferably, the mask is manufactured in a manner that'is the most economical without compromising performance of the mask (e.g, the impermeability of the mask to the chemical signal of interest, the ability to 2o manipulate the mask by hand without breaking or otherwise compromising its operability). The mask may have an adhesive including a pressure sensitive adhesive coated on one or both surfaces. Further, the mask may be coated with a material which absorbs one~.or more compounds or 25 ions flowing in the hydrogel.
~onf ig~urations The mask can be supplied in several different configurations. Examples of these configurations include: 1) the mask supplied in connection with a 3o hydrogel patch; 2) the mask supplied as an integral component of a monitoring device; or 3) the mask supplied as an independent component.
Fig. 5 illustrates how the mask of the invention can be supplied with a hydrogel patch as a hydrogel/mask assembly 12. The mask 1 is.positioned on one face of the gel 3. The mask can be attached to the gel 3 by any suitable chemical means (e.g., adhesive) that do not -affect the impermeability of the mask to the chemical signal of interest or the conductivity of the gel for electrically-induced movement of the chemical signal through the mask opening and into and through the hydrogel. Release liner components 9 and 10 are positioned on opposite surfaces of the assembly 12 to 1o provide improved handleability of the assembly 12 in that the assembly 12 may be slightly fragile (e. g., may tear during shipping or repeated handling) and/or wet and sticky The release liner 10 may include a perforated cut (e. g., an S-shaped cut) or may include two portions 11 and l3.that overlap one another to allow easy removal of the release liner, l0. Prior to use, the release liners 9 and 10 are removed from the assembly 12, and the assembly 12 positioned in the sensor~housing of a monitoring device so that the mask will be in contact 2o with the subject s skin, and the hydrogel will be in contact with the electroosmotic and working electrodes.
In another embodiment, the mask is an integral component of the sensor housing of a monitoring device.
An example of a sensor housing of a.monitoring device is illustrated in Fig. 6~. The sensor housing 16 of the monitoring device includes a top portion 15 containing electroosmotic 5 and working 4 electrodes, and a bottom portion 14 defining an opening 17, the opening having a diameter at least slightly less than that of the mask 1 3o so that the mask fits tightly in the recess 19. The top portion 15 and the bottom portion 14 can be connected by a hinge 18 that permits opening and closing of the sensor housing. The mask 1 is either permanently or re~aovably fitted over this sensor housing opening 17. The edges of the sensor housing opening 17 can define a recess 19 so as to easily receive the mask 1 and seat the mask 1 within the recess 19. The mask can be secured into position in the bottom portion 14 of the sensor housing 16 by any suitable chemical means (e.g., adhesive) or . s physical means (e.g., physically attaching the mask to the opening by melting the edges of the mask 1 edges to the edges of the opening 17), provides that the operability of the mask, the hydrogel, the sensor housing, and/or the monitoring device are not io significantly affected.
The entire assembly is used by inserting a hydrogel patch (as per the gel 3 of Fig. 5) over the mask 1 in the bottom portion 14, and bringing the top portion 15 into position over the bottom portion 14 so that the 15 electroosmotic electrode 5 and working electrodes 4 contact the central portion of the hydrogel. The top portion 15 and the bottom portion l4 can be held together by interconnecting portions of a securing means 19 (e. g., a latch) which can be closed and opened repeatedly, 2o preferably for the life of the sensor housing. The bottom portion 14 is then positioned on the subject's skin so that the hydrogel contained within the bottom portion 14 is in contact with the skin through opening 2.
When properly aligned, the opening 2 in the mask 1 is 25 positioned beneath the approximate center of the catalytic face 6 of the working electrode 4, so that chemical signal that is transported axially through the hydrogel accessible through the mask opening 2 and will come in contact with the central portion of the catalytic 3o face 6 of the working electrode 4. In another embodiment, the mask is supplied as an independent component, e.g. for insertion into a sensor housing as exemplified in Fig. 6. The mask is inserted in the device prior to use as described above and in Fig. 6, the 35 hydrogel inserted within the bottom portion of the sensor housing and on top of the mask, and the device assembled as described above.
Regardless of the embodiment used, all of the masks of the invention: 1) are impermeable to the s chemical signal to be detected; 2) have a diameter that is at least the same or.greater than the diameter of the hydrogel patch used-in conjunction with the mask; and either 3) are configured for use with a working electrode so that when positioned in the path of electrolyte flow io from the chemical signal source, substantially only chemical signal that flows from the source in a direction substantially perpendicular to the working electrode is allowed to enter the electrolyte flow path.
The mask is generally used in conjunction with an 1s electroosmotic electrode (e.g., an iontophoresis or reverse iontophoresis electrode). An electroosmotic electrode suitable for use with the invention is deSCrlbed In PCT W0 96/00109, published January 4, 1996 20 (which discloses an invention invented under an obligation to assign to the same entity as that to which the rights in the present application are assigned)..
The electroosmotic electrode is used to create an 2s electrical field which transports material such as ions and non-polar molecules from one area (e. g., skin, blood and flesh) to the area of the working electrode. It is important the electroosmotic electrode and the working electrode be used alternately (i.e., current is present 3o in the electroosmotic electrode or the electrical current generated at the working electrode is measured -- not both at once).
Working electrodes suitable for use with the invention include any electrode having a catalytic 3s surface for detection of a chemical signal. An example of a suitable working electrode is described in PcT wo 97/10499, published March 20, 1997.
A standard bipotentiostat circuit can be used to bias~the working and scavenging electrodes independently versus the reference electrode.
Based on the description above and in the figures, it will be recognized that the working electrode of the io invention can be configured in a variety of different forms, and from a variety of different materials. The mask will change with the working electrode so as to maintain certain defined mechanical, electrical, chemical and transport (e. g., diffusion) characteristics.
i5 Mechanically the mask will have sufficient structural integrity such that it can be readily handled by human fingers without significant handling difficulties or significantly compromising the performance of the mask. Preferably, the mask will be 2o somewhat flexible so that it can bend at least slightly during.handling without creasing, breaking, or being otherwise compromised in, for example, its impermsability to the chemical signal of interest. The relative mechanical requirements of the mask may vary with the 2s particular mask embodiment. For example, where the mask is an integral part~of the sensor housing, it may be desirable to design the mask so that it can be separated from the patch without significantly tearing the patch, or adhering to the patch in a manner that makes it , 3o difficult to completely remove all patch material from the face of the mask.
The mask must maintain its impermeability to the chemical signal of interest. Preferably, the mask will optimally function at a pH which is relatively close to that from which the chemical signal is withdrawn (e. g, human skin (about 7)) and at least within a range of from about pH 4 to pH 9.
Utili~
The present invention is useful in connection with the detection of biologically significant molecules such as glucose which is moved through human skin using a technique known as electroosmosis. The basic concept of moving a molecule such as a glucose through human skin is disclosed within U.S. PatBnt 5,362,307, issued November 8, 1994 and U.S. Patent 5,279.,543, issued January 18, for disclosing the basic concept of moving molecules such as glucose through human skin by means of electroosmosis.
The concept of converting the very small amounts of molecules such as glucose which can be extracted through the skin in order to create a current by use of glucose OXidaSe is dlsclOSed in PCT WO 96/00109, published January 4, 1996; PCT WO 96/001100 published January 4, 1996;
PCT WO 97/02811, published January 30, 1997 and PCT WO 97/1Q~99, published March 20, 1997, (which applications disclose inventions which were invented under an obligation to assign rights to the same entity to which the rights in the present invention were invented under an obligation to assign.
Fig. 2A illustrates how an exemplary mask of the invention is used in conjunction with a hydrogel/electroosmotic electrode/working electrode system, such as that used in a metabolite monitoring device (e.g., a glucose monitoring device). The mask 1 is positioned on a face of the gel 3 with the opening 2 substantially in the center of the gel 3. A working - 5 electrode 4 and electroosmosis electrode 5 are positioned on the face of the gel 3 opposing the mask 1. The catalytic surface 6 of the working electrode 4 is positioned on the gel 3 so that the working electrode 4 is.directly opposite the opening 2 of the mask 1. The 1o face of the gel 3 attached to the mask 1 is placed on the surface 7 through which the chemical signal is to be diffused (e. g., mammalian skin, e.g., human skin).
During use in monitoring levels of a chemical signal of interest (e. g., glucose), an electrical current 15 is sent through the electroosmotic electrode, thereby drawing molecules through.the patient s skin and into the hydrogel patch. The mask permits entry of the chemical signal into the gel only at the opening 2, thus reducing the amount of chemical signal.that is radially 2o transported into the.patch, as well as the amount of chemical signal that is capable of being transported radially toward the working electrode. The mask creates a column-like flow through the gel to. the working electrode and substantially prevents any material from 25 flowing to the electrode if that material includes a radial vector as a component of its movement, i.e., the material must move axially or perpendicular to the working electrode. The chemical signal permitted into the patch by entry through the opening in the mask is 3o transported in a substantially axial direction toward the catalytic surface 6 of the working electrode 4, where it is converted to an electrical signal. Alternatively, the ' chemical signal is converted into an intermediate compound by a component in the gel 3. The intermediate ' 35 compound in turn is transported to the catalytic surface 6 of the working electrode 4, where it is converted into an electrical signal. The electrical signal is detected by switching off the electroosmotic electrode, and monitoring the electrical current generated at the working electrode.
The use of the mask and advantages associated therewith are.further illustrated by comparing the flow of glucose in a monitoring system either with (Figs. 2A
and 2B) or without (Fig. 3) the mask of the invention.
1o Fig. 3 illustrates an electroosmotic electrode/working electrode/hydrogel patch assembly (without a mask of the invention) for monitoring glucose levels in a mammalian subject (e.g., a human subject). As described above, the electroosmotic electrodes (e. g., iontophoresis electrodes) 5 are activated to electrically draw , glucose 8 through the subject's skin 7 and into the hydrogel 3. The iontophoresis electrode 5 is used-to electrically draw glucose 8 through the subject's skin 7 and into the hydrogel 3. Glucose 8 is permitted to enter 2o the gel 3 over the entire face of the gel 3 in contact with the subject's skin 7. As a result, glucose is present throughout the entire gel 3, rather than in a region substantially perpendicular to the catalytic face 6 of the working electrode 4. The gel 3 contains the enzyme glucose oxidase (GOD), which converts the glucose to hydrogen peroxide and gluconic acid. The conversion of glucose to hydrogen peroxide by GOD is illustrated schematically in Fig. 3. The hydrogen peroxide is transported (e.g., by diffusion) toward the so catalytic face 6 of the working electrode 4, where it is converted into molecular oxygen, 2 hydrogen ions, and 2 electrons, the latter of which provides an electrical signal.
Because glucose is present throughout the entire 3s gel 3, the hydrogen peroxide resulting from enzymatic conversion of glucose is also present throughout the entire gel 3. Because the surface area of the gel is greater~than that of the working electrode, uncatalyzed hydrogen peroxide accumulates at the working electrode 4 s periphery due to radial transport of the compound toward the catalytic~surface 6. Accumulation of peroxide at the working electrode periphery produces a variable hydrogen peroxide flux (i.e.,,the amount of peroxide present over the working_ electrode at a given time is not directly 1o correlated with the actual peroxide flux through. the hydrogel), and thus produces a flux or error in the measured electrical current at the working electrode.
In contrast, and as illustrated in Figs. 2A and 2B, the mask 1 of the invention permits entry of 1s glucose 8 only at the opening 2 (in Fig. 2A) or the non-mask.contacting portion of the gel 3 (as in Figs. 2A and 2B). The opening and/or non-mask contacting gel surface is directly opposite the catalytic surface 6 of the working electrode 4. The glucose 8 is converted into 2o hydrogen peroxide and gluconic acid by GOD, which is contained in the gel 3. The hydrogen peroxide produced is generally positioned within the gel in a region that is beneath and substantially perpendicular to the catalytic.face 6 of the working electrode 4. Thus, the 2s radial transport component of hydrogen peroxide illustrated in Fig. 3 is eliminated, and an increased flux or error in current measured at the working electrode 4 periphery does not occur.
The composition, size and thickness of the mask 3o and other components can be varied and such variance can affect the time over which the components can be used.
For example, the hydrogel patches may be connected to the mask and are generally designed to provide utility over a period of about 24 hours. After that time some ' 35 deterioration in characteristics, sensitivity, and accuracy of the measurements from the electrode can be expected (e. g., due to reduced effectiveness of an enzyme in the hydrogel). Due to other problems the working .
electrode and hydrogel patch, preferably the entire device, should be replaced. The invention contemplates , components,.assemblies and devices which are used over a shorter period of time e.g., 8 to 12 hours or a longer period of time e.g., 1 to 30 days.
In its broader sense, a mask of the invention can 1o be used to carry out a method which comprises extracting any biomedically significant substance through the skin of a human patient and reacting that substance with another substance or substances (which reaction is greatly accelerated by the use of an.enzyme e.g., 10 to 100 times or more as fast) to form a product which is detectable electrochemically by the production of a signal which signal is generated proportionally based on the amount of a biologically important or biomedically significant substance drawn into the patch. As indicated in the above-cited patents the ability to withdraw biochemically significant substances such as glucose through skin has been established (see U.S. Patent Nos.
5,362,307 and 5,279,543). However, the amount of compound withdrawn is often so small that it is not possible to make meaningful use of such methodology in that the withdrawn material cannot be precisely measured and~related to any standard.
Moreover, conventional hydrogel/working electrode assemblies are severely compromised in their ability to 3o accurately, quickly, and continuously monitor levels of the chemical signal. As described above, in devices without a mask chemical signal is radially transported toward the catalytic surface of the working electrode and accumulates at the working electrode periphery, thus causing the flux or error of chemical signal to be greater. at the electrode edges than at the electrode center, a phenomenon termed "edge effects." The edge effects result in varying electrical signals, and thus varying and inadequate measurement of the flux of the ' s chemical signal. The present invention provides an electrode that is capable of detecting the electrochemical signal at very low levels in a manner that allows for direct, accurate correlation between the amount of signal generated and the amount of the molecule (e.g.,, glucose) in the area from which it is moved (e. g., in the human subject).
The invention is remarkable in that it allows for the noninvasive detection and measuring of amounts of a biomedically relevant compound, e.g.,.glucose, at levels i5 that are 1, 2, or even 3 orders of magnitude less than the concentration of that compound in, for example, blood. For example, glucose might be present in blood in a concentration of about 5 millimolar. However, the concentration of glucose in a hydrogel patch which 2o withdraws glucose through skin as described in the system above is on the order of 2 to 100 micromolar. Micromolar amounts are 3 orders of magnitude less than millimolar amounts. The ability to accurately and quickly detect glucose in such small concentrations is attained by 2s constructing the working electrode with the mask and other, components described herein.
~PLES
The foll-owing examples are put forth so as to provide those of ordinary skill.in the art with a 3o complete disclosure and description of how to make and use various specific'asse~blies of the present invention and are not intended to limit the scope of what the inventors regard as their invention. The data presented in these examples are computer-simulated (i.e., the data is generated from a computer model of the mask and electrode assembly described herein). The computer model of the invention uses the following parameters:
glucose diffusivity: 1.3 x 10-6 cm2/sec;
peroxide diffusivity: 1.2 x 10-5 cm2/sec;
enzyme rate constant: 735 sec-l;
KM for glucose: 1.1 .x 105 nmol/ml;
KM for glucose: 200 nmol/ml;
initial oxygen concentration: 240 nmol/ml;
1o enzyme loading in gel: 100 U/ml; and glucose flux: 5 nmol/cm2 hr.
Efforts have been made to~ensure accuracy with respect to numbers used, (e. g., amounts, particular components, etc.) but some deviations should be accounted for. .Unless indicated otherwise, parts are parts by weight, surface area is geometric surface area, temperature is in degrees centigrade, and pressure is at or near atmospheric pressure.
EX~PLE 1 Lg lucose monitoring 'device - no mask) 2o The peroxide flux or. current error at the surface of a platinum working electrode in a glucose monitoring device comprising an iontophoresis electrode/platinum working electrode/hydrogel assembly (no mask) was simulated by computer. The~computer-based experiments were designed to simulate the use of the device in vivo (e. g., the manner in which the device is used to monitor glucose in a .human subject). The computer simulation was based upon a continuous glucose flux into the hydrogel (5 nmol/cm2 hr), 18 U/ml glucose oxidase loaded into the 3o gel, a gel thickness of 600 microns, and alternate intervals of: 1) iontophoresis (i.e., the iontophoresis electrodes are activated, and glucose molecules are electrically drawn through the subject s skin and into and through the hydrogel patch); and 2) detection of an electrical current at the working electrode (i.e., the iontophoresis_electrode is switched off and the sensing unit'to detect electrical current at the working electrode is on). The experimental protocol is shown in s Table 1.
Table 1_: Experimental Protocol for Computer Simulation Interval Interval Length Iontophoresis Working No.' (min) Electrode Electrode 1 15 on of f 2 5 off on 3 15 on of f '4 5 . off on 5 15 on off 6 . 5 off on is This protocol was repeated for a total of 20 intervals.
The results of the computer model are shown in Fig. 7.
These data indicate that the electrical current measured at the working electrode is a function of the interval number, i.e., peroxide flux at the working 2o electrode increases with increasing interval number.
This is a direct result of the accumulation of hydrogen peroxide at the periphery of the working electrode as a result of radial transport of hydrogen peroxide within the gel.toward the electrode. As a result, the device is 25 never able to provide a steady state measurement profile in the presence of a continuous flow of glucose and hydrogen peroxide.

lPLE 2 - with a mask The computer model described in Example 1 was repeated with the same parameters, except that the device included a mask of the invention positioned between the s subjects skin and the hydrogel. The position of the mask.allows transport of glucose toward the working electrode only in a direction that is substantially axial to the catalytic face of the working electrode, and thus production of hydrogen peroxide only in a region of the to hydrogel that is directly beneath the working electrode.
Therefore, the amount of hydrogen peroxide that. is produced at a position outside the perimeter of the working electrode is essentially eliminated.
The results of the computer model, expressed as 1s the measured electrical current as a function of interval number, are shown in Fig. 8. These data indicate that after interval 2, the is independent of interval number.
Thus, within only 2 to 4 intervals, the device provides a steady state profile of the measurement of a continuous 2o flux of hydrogen peroxide.
EXZ~tumhE 3 - with and without a mask The data from the computer simulations of measurement of a constant glucose flux (5 nmol/cm2 hr) using a glucose monitoring device without the mask 25 (Example. l) and with the mask (Example 2) were analyzed to plot the electrical current measured at the working electrode after 5 minutes of measurement versus the interval number (Fig. 9). This analysis shows that in the absence of the mask, there is a strong dependence of 3o the measured electrical current on the interval number.
When the mask of the invention is included in the device, the profile of the measured electrical current is essentially linear, and thus independent of interval number (see "with mask" line of Fig. 9). ' The instant invention is shown and described herein in what is considered to be the most practical, . and preferred embodiments. It is recognized, however, that departures may be made therefrom which are within the scope bf the invention, and that modifications will occur to one skilled in the art upon reading this disclosure.

Claims (41)

What is claimed is:
1. An assembly for use in a monitoring device for monitoring a chemical signal, the chemical signal being a compound which diffuses through the skin of a subject, the assembly comprising:
a) an ionically conductive material having a first face having a chemical signal target area, the ionically conductive material comprising water and an electrolyte; and b) a mask characterized by being substantially impermeable to a chemical signal, the mask being positioned on a second face of the ionically conductive material opposite the first material face such that chemical signal transported through a plane of the mask, through the ionically conductive material, and toward the chemical signal target area is substantially only that chemical signal transported in a direction substantially perpendicular to the chemical signal target area.
2. The assembly of claim 1, wherein the mask has an opening through which chemical signal flows in a direction substantially perpendicular to the target area.
3. The assembly of claim 2, wherein opening in the mask constitutes an area which is in a range of 1% to 90% of an area encompassed by the entire mask plus opening.
4. The assembly of claim 2, wherein the opening in the mask has a perimeter equal to or circumscribed within an outer perimeter of the target area.
5. The assembly of claim 1, wherein the mask is solid and the target area is annular.
6. The assembly of claim 1, wherein the ionically conductive material comprises:

i) a hydrophilic compound which forms a gel in water, which compound is present in an amount of about 4% or more by weight based on the weight of the ionically conductive material;
ii) a hydrogel comprising about 95% or less water; and iii) a chloride containing salt.
7. The assembly of claim 1, wherein the ionically conductive material comprises glucose oxidase and the chemical signal is glucose.
8. The assembly of claim 1, wherein the first and second faces of the ionically conductive material are coplanar and each has a surface area in a range of from about 0.5 to about 10 cm2 and the material has a thickness in a range of from about 5 mils to about 50 mils.
9. The assembly of claim 1, wherein the mask has a thickness in a range of about 0.5 mil to 10 mils and the ionically conductive material has a thickness in a range of about 10 mils to 50 mils.
10. The assembly of claim 1, wherein the mask has a thickness in a range of about 0.5 mil to 10 mils and the ionically conductive material has a thickness in a range of about 10 mils to 60 mils.
11. The assembly of claim 1, wherein the mask has a thickness in a range of about 0.01 mil to 5 mils and the ionically conductive material has a thickness in a range of about 5 mils to 60 mils.
12. The assembly of claim 1, wherein the mask has a thickness in a range of about 0.01 mil to 10 mils and the ionically conductive material has a thickness in a range of about 10 mils to 60 mils.
13. The assembly of claim 1, wherein the mask has a thickness in a range of about 0.5 mil to 5 mils and the ionically conductive material has a thickness in a range of about 5 mils to 60 mils.
14. A sensor assembly for use with a chemical signal monitoring device, comprising;
a sensor housing having a top portion and a bottom portion, the bottom portion defining a bottom portion opening a chemical signal impermeable mask positioned between the top portion and the bottom portion, the mask having a surface area greater than or equal to the surface area of the bottom portion opening, and defining a mask opening, the mask being positioned so that the mask opening and the bottom portion opening are aligned;
and a working electrode positioned in the top portion of the sensor housing;
wherein prior to use of the device a hydrogel is inserted between the sensor housing bottom portion and top portion such that when the sensor assembly is closed, the top portion is positioned directly over the bottom portion such that a first hydrogel face contacts the mask, and the working electrode is in contact with a second hydrogel face opposite the first hydrogel face, the working electrode being positioned directly opposite the bottom portion opening, wherein chemical signal transported through a plane of the mask, through the hydrogel and toward the working electrode is substantially only that chemical signal transported in a direction substantially perpendicular to the working electrode.
15. The sensor assembly of 14, wherein the hydrogel comprises glucose oxidase, the mask is impermeable to glucose, and the working electrode comprises platinum.
16. The sensor assembly of claim 14, wherein the surface area of each the first and second hydrogel faces is in a range of about 0.5 cm2 to 10 cm2.
17. The sensor assembly of claim 14, wherein the mask has a thickness in a range of about 0.5 mils to 10 mils.
18. The sensor assembly of claim 14, wherein the mask has a thickness in the range of about 0.01 mils to 10 mils.
19. The sensor assembly of claim 14, wherein the hydrogel has a thickness in a range of about 10 mils to 50 mils.
20. The sensor assembly of claim 14, wherein the hydrogel has a thickness in a range of about 5 mils to 60 mils.
21. The sensor assembly of claim 14, wherein the assembly has a total thickness in a range of about 5 mils to 50 mils.
22. The sensor assembly of claim 14, wherein the assembly has a total thickness in the range of about 5 mils to 70 mils.
23. An assembly for use in monitoring a chemical signal, comprising:
a) an ionically conductive material comprised of water, electrolyte and an enzyme;
b) a working electrode having a catalytic surface comprised of a material selected from the group consisting of platinum, palladium, nickel, and oxides, dioxides and alloys thereof, the catalytic surface contacting a first face of the ionically conductive material; and c) a chemical signal impermeable mask positioned on a second face of the ionically conductive material (a) opposite the first ionically conductive material face and opposite the catalytic surface of the electrode (b), the mask having an outer perimeter which is equal to or extends beyond an outer perimeter of the working electrode (b) and having an opening therein which has a perimeter which is equal to or circumscribed within the outer perimeter of the working electrode, wherein chemical signal transported through a plane of the mask, through the ionically conductive material, and toward the catalytic surface of the electrode is substantially only that chemical signal transported in a direction substantially perpendicular to the catalytic surface of the electrode.
24. The assembly of claim 23, wherein the material (a), electrode (b), and mask (c) are such that the mask blocks substantially all chemical signal flowing to the catalytic surface which is not flowing in a direction substantially perpendicular to the catalytic surface and allows substantially all chemical signal to flow to the catalytic surface which is flowing to that surface in a substantially perpendicular path.
25. The assembly of claim 23, wherein the first and second faces of the ionically conductive material each have a geometric surface area in a range of about 0.5 cm2 to 10 cm2 and the material has a thickness in range of about 5 to about 50 mils, further wherein the working electrode (b) has a geometric surface area in a range of about 0.25 to about 5.0 cm2, and still further wherein the mask (c) has a thickness in a range of about 0.5 mil to about 10 mils.
26. The assembly of claim 23, wherein the first and second faces of the ionically conductive material each have a geometric surface area in a range of about 0.5 cm2 to 10 cm2 and the material has a thickness in range of about 5 to about 60 mils, further wherein the working electrode (b) has a geometric surface area in a range of about 0.05 cm2 to about 8 cm2, and still further wherein the mask (c) has a thickness in a range of about 0.01 mil to about 10 mils.
27. An assembly for use in a monitoring device for monitoring a chemical signal, comprising:
a) an ionically conductive material;
b) a mask characterized by being impermeable to the chemical signal, the mask being positioned between ionically conductive material and a source of chemical signal; and c) a working electrode which measures chemical signal transported from the source of chemical signal wherein the mask is concentric to the working electrode and further wherein the chemical signal that passes through a plane of the mask is that chemical signal that is transported from the source to the catalytic surface in a manner which is substantially perpendicular to the catalytic surface.
28. The assembly of claim 27, wherein the ionically conductive material is a hydrogel having an enzyme therein and the catalytic surface is comprised of a material selected from the group consisting of platinum, palladium, nickel, oxides thereof, dioxides thereof and alloys thereof.
29. A method of measuring a concentration of a chemical present in a bloodstream of a mammalian subject, comprising the steps of:
contacting a mammalian subject's skin with a sensor assembly comprising;
a) an ionically conductive material in contact with the skin;
b) a working electrode in contact with the ionically conductive material the working electrode having a catalytic surface; and c) a mask having an opening therein wherein the mask is positioned between the skin and the working electrode;
transporting a chemical through the skin and ionically conductive material whereby the mask blocks flow to the catalytic surface except for flow substantially axial to the catalytic surface;
monitoring an electrical signal generated at the working electrode by catalytic conversion into an electric signal at the catalytic surface of the working electrode;
wherein the electrical signal generated at the working electrode over a given period of time is correlated with a concentration of chemical present in the bloodstream of the mammalian subject.
30. The method of claim 29, wherein the assembly further comprises:
d) an electroosmotic electrode in contact with the ionically conductive material and said transporting is accomplished by applying an electrical current to the electroosmotic electrode.
31. The method of claim 29, wherein the chemical is glucose, the ionically conductive material is a hydrogel, and the catalytic surface of the working electrode comprises a material selected from the group consisting of platinum oxide and platinum dioxide.
32. The method of claim 31, wherein the hydrogel comprises a hydrophilic polymer, water and glucose oxidase.
33. The method of claim 32, wherein the mammalian subject is a human.
34. The method of claim 29, wherein the mammalian subject is a human.
35. The method of claim 29, wherein the chemical is glucose.
36. The method of claim 29, wherein the ionically conductive material comprises glucose oxidase.
37. The method of claim 29, wherein the catalytic surface of the working electrode is comprised of a material selected from the group consisting of platinum oxide and platinum dioxide.
38. The method of claim 29, wherein the mammalian subject is a human, the chemical is glucose, the ionically conductive material comprises glucose oxidase, and the surface of the working electrode is comprised of a material selected from the group consisting of platinum oxide and platinum dioxide.
39. A method of measuring a glucose concentration in a mammalian subject, comprising:
contacting a first surface of an ionically conductive material with a skin surface wherein the ionically conductive material comprises water and glucose oxidase;
contacting a second surface of the conductive material with a working electrode;
applying current to the skin in an amount sufficient to draw glucose into the conductive material whereby the glucose is converted to gluconic acid and hydrogen peroxide and the hydrogen peroxide is drawn to the working electrode; and positioning a mask impermeable to the hydrogen peroxide between the skin surface and a surface of the working electrode so as to shield the working electrode surface from hydrogen peroxide moving to the working electrode surface via any path other than a path substantially axial to the working electrode surface.
40. The method of claim 39, wherein the mammalian subject is a human.
41. The method of claim 39, wherein the working electrode is comprised of a material selected from the group consisting of platinum oxide and platinum dioxide.
CA002229509A 1995-09-12 1996-07-16 Chemical signal-impermeable mask Expired - Lifetime CA2229509C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/527,061 1995-09-12
US08/527,061 US5735273A (en) 1995-09-12 1995-09-12 Chemical signal-impermeable mask
PCT/US1996/011776 WO1997010356A1 (en) 1995-09-12 1996-07-16 Chemical signal-impermeable mask

Publications (2)

Publication Number Publication Date
CA2229509A1 CA2229509A1 (en) 1997-03-20
CA2229509C true CA2229509C (en) 2001-10-09

Family

ID=24099938

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002229509A Expired - Lifetime CA2229509C (en) 1995-09-12 1996-07-16 Chemical signal-impermeable mask

Country Status (13)

Country Link
US (7) US5735273A (en)
EP (1) EP0876501B1 (en)
JP (1) JP3366646B2 (en)
KR (1) KR100438509B1 (en)
AT (1) ATE200305T1 (en)
AU (1) AU703849B2 (en)
CA (1) CA2229509C (en)
DE (1) DE69612398T2 (en)
DK (1) DK0876501T3 (en)
ES (1) ES2155615T3 (en)
GR (1) GR3036141T3 (en)
PT (1) PT876501E (en)
WO (1) WO1997010356A1 (en)

Families Citing this family (275)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5771890A (en) 1994-06-24 1998-06-30 Cygnus, Inc. Device and method for sampling of substances using alternating polarity
US20040062759A1 (en) * 1995-07-12 2004-04-01 Cygnus, Inc. Hydrogel formulations for use in electroosmotic extraction and detection of glucose
US5735273A (en) 1995-09-12 1998-04-07 Cygnus, Inc. Chemical signal-impermeable mask
US8734339B2 (en) 1996-12-16 2014-05-27 Ip Holdings, Inc. Electronic skin patch for real time monitoring of cardiac activity and personal health management
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US6001067A (en) 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US8527026B2 (en) 1997-03-04 2013-09-03 Dexcom, Inc. Device and method for determining analyte levels
US6862465B2 (en) 1997-03-04 2005-03-01 Dexcom, Inc. Device and method for determining analyte levels
US7657297B2 (en) * 2004-05-03 2010-02-02 Dexcom, Inc. Implantable analyte sensor
US6139718A (en) 1997-03-25 2000-10-31 Cygnus, Inc. Electrode with improved signal to noise ratio
BR9811609A (en) * 1997-09-05 2000-09-05 Abbott Lab Electrochemical sensor with equalized electrode areas
US7066884B2 (en) * 1998-01-08 2006-06-27 Sontra Medical, Inc. System, method, and device for non-invasive body fluid sampling and analysis
US8287483B2 (en) 1998-01-08 2012-10-16 Echo Therapeutics, Inc. Method and apparatus for enhancement of transdermal transport
US20060015058A1 (en) * 1998-01-08 2006-01-19 Kellogg Scott C Agents and methods for enhancement of transdermal transport
US6134461A (en) * 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6587705B1 (en) 1998-03-13 2003-07-01 Lynn Kim Biosensor, iontophoretic sampling system, and methods of use thereof
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
WO1999058190A1 (en) * 1998-05-13 1999-11-18 Cygnus, Inc. Collection assemblies for transdermal sampling system
EP1077634B1 (en) 1998-05-13 2003-07-30 Cygnus, Inc. Monitoring of physiological analytes
ATE246356T1 (en) 1998-05-13 2003-08-15 Cygnus Therapeutic Systems DEVICE FOR PREDICTING PHYSIOLOGICAL MEASUREMENTS
WO1999058050A1 (en) 1998-05-13 1999-11-18 Cygnus, Inc. Signal processing for measurement of physiological analytes
US6532386B2 (en) 1998-08-31 2003-03-11 Johnson & Johnson Consumer Companies, Inc. Electrotransort device comprising blades
CA2342801A1 (en) 1998-09-04 2000-03-16 Powderject Research Limited Monitoring methods using particle delivery methods
US6602678B2 (en) 1998-09-04 2003-08-05 Powderject Research Limited Non- or minimally invasive monitoring methods
ATE254877T1 (en) 1998-09-17 2003-12-15 Cygnus Therapeutic Systems DEVICE FOR PRESSING A GEL/SENSOR UNIT
DE69908602T2 (en) 1998-09-30 2004-06-03 Cygnus, Inc., Redwood City METHOD AND DEVICE FOR PREDICTING PHYSIOLOGICAL MEASUREMENTS
US6180416B1 (en) 1998-09-30 2001-01-30 Cygnus, Inc. Method and device for predicting physiological values
US6391643B1 (en) 1998-10-28 2002-05-21 Cygnus, Inc. Kit and method for quality control testing of an iontophoretic sampling system
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
EP1135052A1 (en) 1999-02-12 2001-09-26 Cygnus, Inc. Devices and methods for frequent measurement of an analyte present in a biological system
US6959211B2 (en) 1999-03-10 2005-10-25 Optiscan Biomedical Corp. Device for capturing thermal spectra from tissue
ATE290902T1 (en) 1999-04-16 2005-04-15 Johnson & Johnson Consumer DEVICE FOR IONTOPHORETIC ADMINISTRATION OF MEDICATION WITH INTERNAL SENSORS
CA2369336A1 (en) 1999-04-22 2000-11-02 Cygnus, Inc. Hydrogel in an iontophoretic device to measure glucose
US6379324B1 (en) 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6312612B1 (en) 1999-06-09 2001-11-06 The Procter & Gamble Company Apparatus and method for manufacturing an intracutaneous microneedle array
US20050009717A1 (en) * 1999-07-01 2005-01-13 Lukenbach Elvin R. Foaming make-up removing cleansing compositions
US7074747B1 (en) 1999-07-01 2006-07-11 Johnson & Johnson Consumer Companies, Inc. Cleansing compositions
WO2001001949A1 (en) 1999-07-01 2001-01-11 Johnson And Johnson Consumer Companies, Inc. Cleansing compositions
US6762158B2 (en) 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
JP3655587B2 (en) * 1999-09-20 2005-06-02 ロシュ ダイアグノスティックス コーポレーション Small biosensor for continuous analyte monitoring
US7045054B1 (en) * 1999-09-20 2006-05-16 Roche Diagnostics Corporation Small volume biosensor for continuous analyte monitoring
EP1235611B1 (en) * 1999-11-15 2005-09-07 Velcro Industries B.V. Skin attachment member
CA2374751C (en) * 2000-03-17 2009-10-13 Sontra Medical, Inc. System, method, and device for non-invasive body fluid sampling and analysis
US6885883B2 (en) * 2000-05-16 2005-04-26 Cygnus, Inc. Methods for improving performance and reliability of biosensors
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6540675B2 (en) * 2000-06-27 2003-04-01 Rosedale Medical, Inc. Analyte monitor
WO2002015777A1 (en) * 2000-08-18 2002-02-28 Cygnus, Inc. Methods and devices for prediction of hypoglycemic events
WO2002017210A2 (en) 2000-08-18 2002-02-28 Cygnus, Inc. Formulation and manipulation of databases of analyte and associated values
US20020026111A1 (en) * 2000-08-28 2002-02-28 Neil Ackerman Methods of monitoring glucose levels in a subject and uses thereof
US20120191052A1 (en) 2000-10-06 2012-07-26 Ip Holdings, Inc. Intelligent activated skin patch system
US7828827B2 (en) * 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
US6821281B2 (en) 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
US7131987B2 (en) * 2000-10-16 2006-11-07 Corium International, Inc. Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US6663820B2 (en) * 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
US6748250B1 (en) * 2001-04-27 2004-06-08 Medoptix, Inc. Method and system of monitoring a patient
US20090137888A9 (en) * 2001-04-27 2009-05-28 Berman Herbert L System for monitoring of patients
US6591124B2 (en) 2001-05-11 2003-07-08 The Procter & Gamble Company Portable interstitial fluid monitoring system
US6503209B2 (en) 2001-05-18 2003-01-07 Said I. Hakky Non-invasive focused energy blood withdrawal and analysis system
WO2003000127A2 (en) * 2001-06-22 2003-01-03 Cygnus, Inc. Method for improving the performance of an analyte monitoring system
CN1273075C (en) * 2001-07-13 2006-09-06 爱科来株式会社 Analyzing apparatus, piercing element integrally installed body for temperature measuring device with analyzing apparatus, and body fluid sampling apparatus
US20030032874A1 (en) * 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US6631282B2 (en) 2001-08-09 2003-10-07 Optiscan Biomedical Corporation Device for isolating regions of living tissue
US20040087992A1 (en) * 2002-08-09 2004-05-06 Vladimir Gartstein Microstructures for delivering a composition cutaneously to skin using rotatable structures
US6952604B2 (en) 2001-12-21 2005-10-04 Becton, Dickinson And Company Minimally-invasive system and method for monitoring analyte levels
US7004928B2 (en) 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US7828728B2 (en) 2003-07-25 2010-11-09 Dexcom, Inc. Analyte sensor
DE60334365D1 (en) 2002-03-22 2010-11-11 Animas Technologies Llc INCREASED PERFORMANCE OF AN ANALYSIS MONITORING DEVICE
US6801804B2 (en) 2002-05-03 2004-10-05 Aciont, Inc. Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis
US7150975B2 (en) * 2002-08-19 2006-12-19 Animas Technologies, Llc Hydrogel composition for measuring glucose flux
EP1540351A4 (en) * 2002-08-30 2007-06-06 Biochec Co Ltd Glucose extraction patch and its manufacturing process
US20040122500A1 (en) * 2002-12-19 2004-06-24 Kimberly-Clark Worldwide, Inc. Electrode for utilizing edge effect to create uniform current density
US7174198B2 (en) * 2002-12-27 2007-02-06 Igor Trofimov Non-invasive detection of analytes in a complex matrix
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US7578954B2 (en) * 2003-02-24 2009-08-25 Corium International, Inc. Method for manufacturing microstructures having multiple microelements with through-holes
US7052652B2 (en) * 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
JP4381705B2 (en) * 2003-03-26 2009-12-09 シスメックス株式会社 Transcutaneous analyte extraction system and analysis system, and transcutaneous analyte extraction method and analysis method
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US7134999B2 (en) * 2003-04-04 2006-11-14 Dexcom, Inc. Optimized sensor geometry for an implantable glucose sensor
US7415299B2 (en) * 2003-04-18 2008-08-19 The Regents Of The University Of California Monitoring method and/or apparatus
JP2004343275A (en) * 2003-05-14 2004-12-02 Murata Mach Ltd Image processing system and scanner
US7258673B2 (en) * 2003-06-06 2007-08-21 Lifescan, Inc Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
JP2007500336A (en) * 2003-07-25 2007-01-11 デックスコム・インコーポレーテッド Electrode system for electrochemical sensors
US7108778B2 (en) * 2003-07-25 2006-09-19 Dexcom, Inc. Electrochemical sensors including electrode systems with increased oxygen generation
JP4708342B2 (en) 2003-07-25 2011-06-22 デックスコム・インコーポレーテッド Oxygen augmentation membrane system for use in implantable devices
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US8060173B2 (en) 2003-08-01 2011-11-15 Dexcom, Inc. System and methods for processing analyte sensor data
US8676287B2 (en) 2003-08-01 2014-03-18 Dexcom, Inc. System and methods for processing analyte sensor data
US20050069925A1 (en) * 2003-08-15 2005-03-31 Russell Ford Microprocessors, devices, and methods for use in monitoring of physiological analytes
US7189341B2 (en) * 2003-08-15 2007-03-13 Animas Technologies, Llc Electrochemical sensor ink compositions, electrodes, and uses thereof
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
DE602004029092D1 (en) 2003-12-05 2010-10-21 Dexcom Inc CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTIC SENSOR
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8017145B2 (en) * 2003-12-22 2011-09-13 Conopco, Inc. Exfoliating personal care wipe article containing an array of projections
US8165651B2 (en) * 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
WO2005084257A2 (en) * 2004-02-26 2005-09-15 Vpn Solutions, Llc Composite thin-film glucose sensor
WO2005094526A2 (en) * 2004-03-24 2005-10-13 Corium International, Inc. Transdermal delivery device
US20050245799A1 (en) * 2004-05-03 2005-11-03 Dexcom, Inc. Implantable analyte sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US20160192880A9 (en) * 2004-05-28 2016-07-07 David Scott Utley Intra-Oral Detector and System for Modification of Undesired Behaviors and Methods Thereof
US20060010098A1 (en) 2004-06-04 2006-01-12 Goodnow Timothy T Diabetes care host-client architecture and data management system
GB2414675B (en) * 2004-06-05 2006-09-06 Dewan Fazlul Hoque Chowdhury Transdermal drug delivery device
US20080242961A1 (en) * 2004-07-13 2008-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US7946984B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
WO2006127694A2 (en) 2004-07-13 2006-11-30 Dexcom, Inc. Analyte sensor
US20060016700A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
IL163796A0 (en) * 2004-08-30 2005-12-18 Gribova Orna A Device for detecting changes in blood glucose level or dardiovacular condition
JP5502279B2 (en) * 2004-10-28 2014-05-28 エコー セラピューティクス, インコーポレイテッド System and method for analyte sampling and analysis using hydrogels
US20060094945A1 (en) * 2004-10-28 2006-05-04 Sontra Medical Corporation System and method for analyte sampling and analysis
JP2006167428A (en) * 2004-11-16 2006-06-29 Sysmex Corp Analyte extraction device, analyzer, analyte extraction method, and analysis method
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US20090076360A1 (en) 2007-09-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
CA2602259A1 (en) * 2005-03-29 2006-10-05 Arkal Medical, Inc. Devices, systems, methods and tools for continuous glucose monitoring
WO2007081378A1 (en) * 2005-04-29 2007-07-19 Byrne Norman R Center connect single-sided junction block
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
KR100692783B1 (en) * 2005-07-19 2007-03-12 케이엠에이치 주식회사 Patch for extracting glucose
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
EP1928304B1 (en) 2005-09-30 2012-10-24 Intuity Medical, Inc. Catalysts for body fluid sample extraction
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7432069B2 (en) * 2005-12-05 2008-10-07 Sontra Medical Corporation Biocompatible chemically crosslinked hydrogels for glucose sensing
JP2009520187A (en) * 2005-12-16 2009-05-21 バイエル・ヘルスケア・エルエルシー Transcutaneous analyte sensor assembly and method of use thereof
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7981034B2 (en) 2006-02-28 2011-07-19 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
JP2009528121A (en) * 2006-03-01 2009-08-06 ジー.アール. エンライトンメント エルティーディー. Apparatus and method for measuring parameters related to electrochemical processes
US20090131778A1 (en) * 2006-03-28 2009-05-21 Jina Arvind N Devices, systems, methods and tools for continuous glucose monitoring
US20080154107A1 (en) * 2006-12-20 2008-06-26 Jina Arvind N Device, systems, methods and tools for continuous glucose monitoring
US20100049021A1 (en) * 2006-03-28 2010-02-25 Jina Arvind N Devices, systems, methods and tools for continuous analyte monitoring
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
WO2007143225A2 (en) 2006-06-07 2007-12-13 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US8206296B2 (en) 2006-08-07 2012-06-26 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US8932216B2 (en) 2006-08-07 2015-01-13 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US20080058726A1 (en) * 2006-08-30 2008-03-06 Arvind Jina Methods and Apparatus Incorporating a Surface Penetration Device
GB2441784A (en) * 2006-09-13 2008-03-19 Rtc North Ltd Device for obtaining and analysing a biological fluid
US7831287B2 (en) * 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
WO2008091602A2 (en) * 2007-01-22 2008-07-31 Corium International, Inc. Applicators for microneedle arrays
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8812071B2 (en) * 2007-03-07 2014-08-19 Echo Therapeutics, Inc. Transdermal analyte monitoring systems and methods for analyte detection
US20080234562A1 (en) * 2007-03-19 2008-09-25 Jina Arvind N Continuous analyte monitor with multi-point self-calibration
CA2681412A1 (en) 2007-03-26 2008-10-02 Dexcom, Inc. Analyte sensor
US9114238B2 (en) 2007-04-16 2015-08-25 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
US8386027B2 (en) 2007-04-27 2013-02-26 Echo Therapeutics, Inc. Skin permeation device for analyte sensing or transdermal drug delivery
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20080312518A1 (en) * 2007-06-14 2008-12-18 Arkal Medical, Inc On-demand analyte monitor and method of use
US8641618B2 (en) 2007-06-27 2014-02-04 Abbott Diabetes Care Inc. Method and structure for securing a monitoring device element
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US9968742B2 (en) 2007-08-29 2018-05-15 Medtronic Minimed, Inc. Combined sensor and infusion set using separated sites
US20120046533A1 (en) 2007-08-29 2012-02-23 Medtronic Minimed, Inc. Combined sensor and infusion sets
WO2009048607A1 (en) 2007-10-10 2009-04-16 Corium International, Inc. Vaccine delivery via microneedle arrays
JP5178132B2 (en) * 2007-10-11 2013-04-10 キヤノン株式会社 Image processing system and image processing method
US20090099427A1 (en) * 2007-10-12 2009-04-16 Arkal Medical, Inc. Microneedle array with diverse needle configurations
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
CA2702799A1 (en) 2007-10-25 2009-04-30 Dexcom, Inc. Systems and methods for processing sensor data
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
CN102047101A (en) 2008-03-28 2011-05-04 德克斯康公司 Polymer membranes for continuous analyte sensors
WO2009131738A2 (en) * 2008-04-23 2009-10-29 Elc Management Llc Microcurrent-generating topical or cosmetic systems, and methods of making and using the same
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
WO2009145920A1 (en) 2008-05-30 2009-12-03 Intuity Medical, Inc. Body fluid sampling device -- sampling site interface
EP2299904B1 (en) 2008-06-06 2019-09-11 Intuity Medical, Inc. Medical measurement method
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
GB0811874D0 (en) * 2008-06-30 2008-07-30 Nemaura Pharma Ltd Patches for reverse iontophoresis
WO2010009172A1 (en) 2008-07-14 2010-01-21 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
GB2467377A (en) 2009-02-02 2010-08-04 Nemaura Pharma Ltd Transdermal patch with extensor means actuated to expel drug towards the skin of a patient
US9402544B2 (en) * 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
CA2759850C (en) * 2009-04-24 2019-10-22 Corium International, Inc. Methods for manufacturing microprojection arrays
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US8483967B2 (en) 2009-04-29 2013-07-09 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US9184490B2 (en) 2009-05-29 2015-11-10 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US8498694B2 (en) * 2009-07-13 2013-07-30 Entrotech, Inc. Subcutaneous access device and related methods
EP3936032A1 (en) 2009-07-23 2022-01-12 Abbott Diabetes Care, Inc. Real time management of data relating to physiological control of glucose levels
EP3923295A1 (en) 2009-08-31 2021-12-15 Abbott Diabetes Care, Inc. Medical devices and methods
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
WO2011026148A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US20110082356A1 (en) 2009-10-01 2011-04-07 Medtronic Minimed, Inc. Analyte sensor apparatuses having interference rejection membranes and methods for making and using them
US20110288388A1 (en) 2009-11-20 2011-11-24 Medtronic Minimed, Inc. Multi-conductor lead configurations useful with medical device systems and methods for making and using them
EP3106871B1 (en) 2009-11-30 2021-10-27 Intuity Medical, Inc. A method of verifying the accuracy of the operation of an analyte monitoring device
US8660628B2 (en) 2009-12-21 2014-02-25 Medtronic Minimed, Inc. Analyte sensors comprising blended membrane compositions and methods for making and using them
EP2533694A1 (en) 2010-02-10 2012-12-19 Baylor University Ultra-wide band non-invasive biological sensor and method
US10448872B2 (en) 2010-03-16 2019-10-22 Medtronic Minimed, Inc. Analyte sensor apparatuses having improved electrode configurations and methods for making and using them
ES2881798T3 (en) 2010-03-24 2021-11-30 Abbott Diabetes Care Inc Medical device inserters and medical device insertion and use procedures
WO2011140274A2 (en) 2010-05-04 2011-11-10 Corium International, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
GB201008448D0 (en) 2010-05-20 2010-07-07 Univ Strathclyde Transdermal device
US9215995B2 (en) 2010-06-23 2015-12-22 Medtronic Minimed, Inc. Sensor systems having multiple probes and electrode arrays
CA2803797A1 (en) 2010-06-25 2011-12-29 Intuity Medical, Inc. Analyte monitoring methods and systems
US9029168B2 (en) * 2010-06-28 2015-05-12 The Trustees Of Princeton University Use and making of biosensors utilizing antimicrobial peptides for highly sensitive biological monitoring
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
DK3575796T3 (en) 2011-04-15 2021-01-18 Dexcom Inc ADVANCED ANALYZE SENSOR CALIBRATION AND ERROR DETECTION
US9008744B2 (en) 2011-05-06 2015-04-14 Medtronic Minimed, Inc. Method and apparatus for continuous analyte monitoring
EP3407064B1 (en) 2011-08-03 2020-04-22 Intuity Medical, Inc. Body fluid sampling arrangement
WO2013032940A1 (en) 2011-08-26 2013-03-07 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US9493807B2 (en) 2012-05-25 2016-11-15 Medtronic Minimed, Inc. Foldover sensors and methods for making and using them
US20140012115A1 (en) 2012-07-03 2014-01-09 Medtronic Minimed, Inc. Plasma deposited adhesion promoter layers for use with analyte sensors
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9788765B2 (en) 2012-09-28 2017-10-17 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
US10194840B2 (en) 2012-12-06 2019-02-05 Medtronic Minimed, Inc. Microarray electrodes useful with analyte sensors and methods for making and using them
ES2743404T3 (en) 2012-12-21 2020-02-19 Corium Inc Matrix for therapeutic agent supply and manufacturing method
US10426383B2 (en) 2013-01-22 2019-10-01 Medtronic Minimed, Inc. Muting glucose sensor oxygen response and reducing electrode edge growth with pulsed current plating
EP2968887B1 (en) 2013-03-12 2022-05-04 Corium, Inc. Microprojection applicators
AU2014237279B2 (en) 2013-03-15 2018-11-22 Corium Pharma Solutions, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
CA2903459C (en) 2013-03-15 2024-02-20 Corium International, Inc. Multiple impact microprojection applicators and methods of use
EP2968118B1 (en) 2013-03-15 2022-02-09 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
EP2968119B1 (en) 2013-03-15 2019-09-18 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US10729386B2 (en) 2013-06-21 2020-08-04 Intuity Medical, Inc. Analyte monitoring system with audible feedback
US20150122647A1 (en) 2013-11-07 2015-05-07 Medtronic Minimed, Inc. Enzyme matrices for use with ethylene oxide sterilization
CA2933166C (en) 2013-12-31 2020-10-27 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
EP3188714A1 (en) 2014-09-04 2017-07-12 Corium International, Inc. Microstructure array, methods of making, and methods of use
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
ITUB20154036A1 (en) * 2015-09-30 2017-03-30 St Microelectronics Srl BIOSENSOR FOR DETECTION OF ANALYTES IN SWEAT, AND METHOD OF MANUFACTURE OF THE BIOSENSOR
JP6116075B1 (en) * 2015-11-20 2017-04-19 日本航空電子工業株式会社 Electrochemical measurement method, electrochemical measurement apparatus and transducer
WO2017117472A1 (en) 2015-12-30 2017-07-06 Dexcom, Inc. Biointerface layer for analyte sensors
US10324058B2 (en) 2016-04-28 2019-06-18 Medtronic Minimed, Inc. In-situ chemistry stack for continuous glucose sensors
US11179078B2 (en) 2016-06-06 2021-11-23 Medtronic Minimed, Inc. Polycarbonate urea/urethane polymers for use with analyte sensors
US11134868B2 (en) 2017-03-17 2021-10-05 Medtronic Minimed, Inc. Metal pillar device structures and methods for making and using them in electrochemical and/or electrocatalytic applications
US10856784B2 (en) 2017-06-30 2020-12-08 Medtronic Minimed, Inc. Sensor initialization methods for faster body sensor response
US20190223771A1 (en) 2018-01-23 2019-07-25 Medtronic Minimed, Inc. Implantable polymer surfaces exhibiting reduced in vivo inflammatory responses
US11186859B2 (en) 2018-02-07 2021-11-30 Medtronic Minimed, Inc. Multilayer electrochemical analyte sensors and methods for making and using them
US11220735B2 (en) 2018-02-08 2022-01-11 Medtronic Minimed, Inc. Methods for controlling physical vapor deposition metal film adhesion to substrates and surfaces
US11583213B2 (en) 2018-02-08 2023-02-21 Medtronic Minimed, Inc. Glucose sensor electrode design
EP3794135A1 (en) 2018-05-16 2021-03-24 Medtronic MiniMed, Inc. Thermally stable glucose limiting membrane for glucose sensors
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
US11718865B2 (en) 2019-07-26 2023-08-08 Medtronic Minimed, Inc. Methods to improve oxygen delivery to implantable sensors
US11523757B2 (en) 2019-08-01 2022-12-13 Medtronic Minimed, Inc. Micro-pillar working electrodes design to reduce backflow of hydrogen peroxide in glucose sensor
US20220031205A1 (en) 2020-07-31 2022-02-03 Medtronic Minimed, Inc. Sensor identification and integrity check design
US20220133190A1 (en) 2020-10-29 2022-05-05 Medtronic Minimed, Inc. Glucose biosensors comprising direct electron transfer enzymes and methods of making and using them
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter
US20220240823A1 (en) 2021-01-29 2022-08-04 Medtronic Minimed, Inc. Interference rejection membranes useful with analyte sensors
CN113008966B (en) * 2021-03-04 2021-09-28 西南交通大学 Non-enzymatic electrochemical sensor capable of simultaneously detecting glucose and uric acid
US20220338768A1 (en) 2021-04-09 2022-10-27 Medtronic Minimed, Inc. Hexamethyldisiloxane membranes for analyte sensors
US20230053254A1 (en) 2021-08-13 2023-02-16 Medtronic Minimed, Inc. Dry electrochemical impedance spectroscopy metrology for conductive chemical layers
US20230113175A1 (en) 2021-10-08 2023-04-13 Medtronic Minimed, Inc. Immunosuppressant releasing coatings
US20230123613A1 (en) 2021-10-14 2023-04-20 Medtronic Minimed, Inc. Sensors for 3-hydroxybutyrate detection
US20230172497A1 (en) 2021-12-02 2023-06-08 Medtronic Minimed, Inc. Ketone limiting membrane and dual layer membrane approach for ketone sensing
CN115165984B (en) * 2022-07-15 2023-06-06 中国科学院海洋研究所 Ocean environment hydrogen permeation monitoring sensor with working face being plane and monitoring method
US20240023849A1 (en) 2022-07-20 2024-01-25 Medtronic Minimed, Inc. Acrylate hydrogel membrane for dual function of diffusion limiting membrane as well as attenuation to the foreign body response

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4633879A (en) * 1979-11-16 1987-01-06 Lec Tec Corporation Electrode with disposable interface member
US4477971A (en) * 1981-11-06 1984-10-23 Motion Control, Inc. Iontophoretic electrode structure
US4457748A (en) * 1982-01-11 1984-07-03 Medtronic, Inc. Non-invasive diagnosis method
DK8601218A (en) * 1984-07-18 1986-03-17
US4702732A (en) * 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
US4960467A (en) * 1985-02-11 1990-10-02 The United States Of America As Represented By The Secretary Of The Army Dermal substance collection device
US4909256A (en) * 1985-02-11 1990-03-20 The United States Of America, As Represented By The Secretary Of The Army Transdermal vapor collection method and apparatus
US4657748A (en) * 1985-03-18 1987-04-14 Exxon Research And Engineering Company Crystalline zeolite (ECR-1) and process for preparing it
US4732155A (en) * 1985-08-27 1988-03-22 The Children's Medical Center Corporation Implantable chemoattractant system
US4894339A (en) * 1985-12-18 1990-01-16 Seitaikinouriyou Kagakuhin Sinseizogijutsu Kenkyu Kumiai Immobilized enzyme membrane for a semiconductor sensor
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4752285B1 (en) * 1986-03-19 1995-08-22 Univ Utah Res Found Methods and apparatus for iontophoresis application of medicaments
US4722761A (en) * 1986-03-28 1988-02-02 Baxter Travenol Laboratories, Inc. Method of making a medical electrode
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US4731049A (en) * 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
US4821733A (en) * 1987-08-18 1989-04-18 Dermal Systems International Transdermal detection system
AU614092B2 (en) * 1987-09-11 1991-08-22 Paul Max Grinwald Improved method and apparatus for enhanced drug permeation of skin
WO1989006989A1 (en) * 1988-01-29 1989-08-10 The Regents Of The University Of California Iontophoretic non-invasive sampling or delivery device
US5362307A (en) * 1989-01-24 1994-11-08 The Regents Of The University Of California Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
US5203327A (en) * 1988-09-08 1993-04-20 Sudor Partners Method and apparatus for determination of chemical species in body fluid
US5076273A (en) * 1988-09-08 1991-12-31 Sudor Partners Method and apparatus for determination of chemical species in body fluid
US5057072A (en) * 1988-10-28 1991-10-15 Medtronic, Inc. Iontophoresis electrode
US4968297A (en) * 1989-05-09 1990-11-06 Iomec, Inc. Iontophoretic electrode with solution containment system
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
US5140985A (en) * 1989-12-11 1992-08-25 Schroeder Jon M Noninvasive blood glucose measuring device
US5036861A (en) * 1990-01-11 1991-08-06 Sembrowich Walter L Method and apparatus for non-invasively monitoring plasma glucose levels
US5161532A (en) * 1990-04-19 1992-11-10 Teknekron Sensor Development Corporation Integral interstitial fluid sensor
WO1992007609A1 (en) * 1990-10-29 1992-05-14 Angeion Corporation Digital display system for balloon catheter
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
US5156591A (en) * 1990-12-13 1992-10-20 S. I. Scientific Innovations Ltd. Skin electrode construction and transdermal drug delivery device utilizing same
DK0592418T3 (en) * 1991-07-12 1995-10-09 Grimma Masch Anlagen Gmbh Process and apparatus for detecting combustion gases from waste incineration plants
US5322063A (en) * 1991-10-04 1994-06-21 Eli Lilly And Company Hydrophilic polyurethane membranes for electrochemical glucose sensors
DE69519023T2 (en) * 1994-06-24 2001-06-13 Cygnus Therapeutic Systems IONTOPHORETIC SAMPLING DEVICE
US5771890A (en) * 1994-06-24 1998-06-30 Cygnus, Inc. Device and method for sampling of substances using alternating polarity
US5735273A (en) * 1995-09-12 1998-04-07 Cygnus, Inc. Chemical signal-impermeable mask

Also Published As

Publication number Publication date
US6529755B2 (en) 2003-03-04
JPH11512316A (en) 1999-10-26
DE69612398T2 (en) 2001-07-12
WO1997010356A1 (en) 1997-03-20
AU6497396A (en) 1997-04-01
KR19990044567A (en) 1999-06-25
DK0876501T3 (en) 2001-05-14
US20030120138A1 (en) 2003-06-26
PT876501E (en) 2001-07-31
US5827183A (en) 1998-10-27
US20020062073A1 (en) 2002-05-23
EP0876501B1 (en) 2001-04-04
CA2229509A1 (en) 1997-03-20
KR100438509B1 (en) 2004-11-16
GR3036141T3 (en) 2001-09-28
ES2155615T3 (en) 2001-05-16
US20010020125A1 (en) 2001-09-06
EP0876501A1 (en) 1998-11-11
US6370410B2 (en) 2002-04-09
US6201979B1 (en) 2001-03-13
AU703849B2 (en) 1999-04-01
DE69612398D1 (en) 2001-05-10
US6771995B2 (en) 2004-08-03
US5735273A (en) 1998-04-07
JP3366646B2 (en) 2003-01-14
US6141573A (en) 2000-10-31
ATE200305T1 (en) 2001-04-15

Similar Documents

Publication Publication Date Title
CA2229509C (en) Chemical signal-impermeable mask
US5989409A (en) Method for glucose sensing
US6284126B1 (en) Electrode with improved signal to noise ratio
US5954685A (en) Electrochemical sensor with dual purpose electrode
CA2329411C (en) Collection assemblies for transdermal sampling system
CA2265119C (en) Biosensor, iontophoretic sampling system, and methods of use thereof
JP2002524178A (en) Press equipment for gel / sensor assembly
JP2002528190A (en) Kits and methods for quality control testing of iontophoretic sampling systems
Yang et al. An Integrated Needle‐Type Biosensor for Intravascular Glucose and Lactate Monitoring

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20160718